{
    "code": 0,
    "data": [
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2025 Held Today August 13 2025",
            "news_body": "Unaudited Financial results for the quarter ended June 30 2025",
            "news_id": "84198b56-fe34-4702-97b1-5ac26574d94d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f866d67-cbc6-4d5e-8a13-caf26cc7468e.pdf",
            "news_date": "2025-08-13 16:58:44",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended December 31, 2023.",
            "news_body": "Financial results for the quarter ended December 31, 2023.",
            "news_id": "3ff53df9-f5ac-4d0a-9674-3e956f4db832",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98d24415-4ba4-46c2-a57c-28a5e4a59cc1.pdf",
            "news_date": "2024-02-09 14:40:58",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Pfizer Limited Unaudited Financial Results - September 30 2023",
            "news_body": "Pfizer Limited Unaudited Financial Results - September 30 2023",
            "news_id": "c3c39509-d51a-4cc4-ae6e-353145394bdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da6c0040-80fb-4e8e-845d-c52d447245f9.pdf",
            "news_date": "2023-10-28 15:51:57",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Pfizer Limited - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023.",
            "news_body": "Pfizer Limited - Unaudited financial results for the quarter and half year ended September 30, 2023",
            "news_id": "dc8aea1b-fd2c-4443-bc8d-45f128dd6c1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a32a3ff-53f4-4eff-bcdc-65f62fa9e6ce.pdf",
            "news_date": "2023-10-28 15:26:47",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Pfizer Limited Unaudited Financial Results - Quarter Ended June 30, 2023",
            "news_body": "Pfizer Limited Unaudited Financial Results - Quarter ended June 30, 2023",
            "news_id": "251071f3-18fd-4957-b994-7a7602adf308",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9272725c-fff2-4c37-a32f-ff5252b41c28.pdf",
            "news_date": "2023-08-11 20:54:38",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Pfizer Limited - Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Pfizer Limited - Unaudited Financial Results for the quarter ended June 30, 2023",
            "news_id": "0b7d9807-c182-4f98-a2db-dfa9e70ddd92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccd85299-f797-412f-bc21-49b7fc33eb37.pdf",
            "news_date": "2023-08-11 16:29:19",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Audited Financial Results And Audit Report For The Financial Year Ended March 31, 2023 - Outcome Of Board Meeting.",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the audited financial results for the financial year ended March 31, 2023, Statement of Assets and Liabilities as on March 31, 2023, Statement of Audited Cash Flows for the year ended March 31, 2023, Declaration with respect to Audit Report with unmodified opinion and the Auditor''s Report by our Statutory Auditors, M/s. B S R & Co., LLP, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 3.00 p.m. and concluded at 5.45 p.m.<BR> <BR> <BR> We request you to kindly take the same on record.",
            "news_id": "aea8ee97-53da-4db2-87fb-79a666d00f43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06758cd0-a967-4018-8338-9a4fab2a2581.pdf",
            "news_date": "2023-05-15 17:53:41",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022.",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit Herewith the unaudited financial results for the third quarter<BR> and nine months ended December 31, 2022. The said results were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.45 p.m. and<BR> concluded at 4.30 p.m.<BR> <BR> Also please find enclosed the Limited Review Report by our Auditors M/s. B S R & Co., LLP, in respect of the above results.<BR> Please take the above on record.",
            "news_id": "926437cd-542d-4d33-8acd-77303cb01f21",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c26de54-f443-424b-9453-37d2638e9041.pdf",
            "news_date": "2023-02-09 16:48:14",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022.",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the third quarter and nine months ended December 31, 2022. The said results were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.45 p.m. and concluded at 4.30 p.m.<BR> <BR> Also please find enclosed the Limited Review Report by our Auditors M/s. B S R & Co., LLP, in respect of the above results.<BR> <BR> Please take the above on record.",
            "news_id": "76cdc5d3-b530-47cc-9c17-cae109166a2d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=327ed073-ae66-4e81-a144-b60eeca54035.pdf",
            "news_date": "2023-02-09 16:42:20",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2022.The said disclosure is also available on the website of the Company i.e., www.pfizerltd.co.inPlease take the above on record",
            "news_id": "d71168e5-e7f9-48c3-8509-dbb0499e7e3a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e0ef56b-63e0-4d56-a30a-cf6e4feaa2a8.pdf",
            "news_date": "2022-11-25 16:27:46",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended<BR> September 30, 2022",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter and<BR> half year ended September 30, 2022. The said results were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.15 p.m. and<BR> concluded at 4.00 p.m.<BR> <BR> Also please find enclosed the Limited Review Report by our Auditors M/s. B S R & Co., LLP, in respect of the above results.<BR> <BR> Please take the above on record",
            "news_id": "30f0bb45-0890-4a36-be8d-f7e87784d1fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dba428df-8ce6-4487-aff8-e48699a90570.pdf",
            "news_date": "2022-11-11 16:15:33",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Pfizer Limited - Unaudited Financial Results For The Quarter Ended June 30, 2022.",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements)<BR> Regulations, 2015, we submit herewith the unaudited financial results for the quarter<BR> ended June 30, 2022, which were approved by the Board of Directors of the Company at its<BR> Meeting held today, that commenced at 12:00 noon and concluded at 2:45 p.m.<BR> Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok<BR> & Co LLP, in respect of the above results.",
            "news_id": "c3f0aad4-98e3-4e12-8ac1-b5f8634f85b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be0ca2e2-65ab-42fa-a7ea-846cf16e4c90.pdf",
            "news_date": "2022-08-05 15:10:59",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accountingstandards for the half year ended March 31, 2022.The said disclosure is also available on the website of the Company i.e., www.pfizerindia.com",
            "news_id": "6c36b8d8-3a58-4314-80f6-cefad24b0fd3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f8b4a7a-8695-4e10-8797-48990661be58.pdf",
            "news_date": "2022-06-03 17:45:21",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Audit Report For The Financial Year Ended  March 31, 2022 - Outcome Of Board Meeting - Regulation 30.",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligation Disclosure Requirements)  Regulations, 2015, we submit herewith audited financial results for the financial year ended  March 31, 2022, Statement of Assets and Liabilities as on March 31, 2022, Statement of  Audited Cash Flows for the year ended March 31, 2022, Declaration with respect to Audit <BR> Report with unmodified opinion and the Auditor''s Report by Auditors,  M/s. Walker Chandiok & Co LLP, which were approved by the Board of Directors of the  Company at its Meeting held today, that commenced at 5.00 p.m. and concluded at  7.15 p.m. <BR> The Board of Directors have at its Meeting held today, i.e., May 20, 2022, recommended a  dividend of Rs. 35/- per equity share of Rs. 10/- each {350%) for the financial year ended  March 31, 2022. The said dividend, if declared at the ensuing Annual General Meeting of  the Company shall be paid on or before September 23, 2022.<BR>",
            "news_id": "81e571b6-0274-43e0-ba03-e919aa070362",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf08ee95-856d-484f-8df7-cbc380d8a877.pdf",
            "news_date": "2022-05-20 19:38:17",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the third quarter<BR> and nine months ended December 31, 2021, which were approved by the Board of Directors of the Company at its meeting held today, that commenced at 12.30 p.m. and concluded at 4.15 p.m.<BR> <BR> Also please find enclosed the Limited Review Report by our Auditors - M/s. Walker Chandiok & Co LLP, in respect of the above results.<BR> <BR> Please take the above on record.",
            "news_id": "6eb17e49-8fb2-48bf-b3ff-604753597fa3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=add65488-2e10-4549-a70c-b9ce6faebcd3.pdf",
            "news_date": "2022-02-03 16:36:18",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended<BR> September 30, 2021",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we submit herewith the unaudited financial results for the quarter and<BR> half year ended September 30, 2021, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 4.00 p.m. and concluded at<BR> 6.00 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results.<BR> Please take the above on record.",
            "news_id": "0b00848f-3da8-4249-bb30-2eec71e35d50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee095627-bb64-4417-b24c-57b9e3ffd48e.pdf",
            "news_date": "2021-11-03 18:23:07",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended June 30, 2021, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 11.30 a.m. and concluded at 2.00 p.m.<BR> <BR> Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results.<BR> <BR> Please take the above on record.",
            "news_id": "1b168bfe-5693-4ed5-99a0-513df7428184",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52d5c3af-cbbd-4b2c-91b9-52c76226c396.pdf",
            "news_date": "2021-07-28 14:18:10",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Audit Report For The Financial Year Ended<BR> March 31, 2021",
            "news_body": "We submit herewith audited financial results for the financial year ended<BR> March 31, 2021, Statement of Assets and Liabilities as on March 31, 2021, Statement of<BR> Audited Cash Flows for the year ended March 31, 2021, Declaration with respect to Audit<BR> Report with unmodified opinion and the Auditor's Report by Auditors,<BR> M/s. Walker Chandiok & Co LLP, which were approved by the Board of Directors of the<BR> Company at its Meeting held today, that commenced at 2.15 p.m. and concluded at<BR> 4.00 p.m.<BR> Further, please be informed that the Board of Directors of the Company has recommended<BR> a normal dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) and a special dividend<BR> of Rs. 5/- per equity share of Rs. 10/- each (50%), aggregating to total dividend of<BR> Rs. 35/- per equity share of Rs. 10/- each (350%) for the year ended March 31, 2021.<BR> The said dividend, if declared at the ensuing Annual General Meeting of the Company shall<BR> be paid on or before September 15, 2021.",
            "news_id": "e3550abf-7687-4deb-95d0-91436d127fe7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0be1966f-edf8-4291-aa14-931526fed76c.pdf",
            "news_date": "2021-05-26 16:36:36",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PFIZER",
            "disp": "Pfizer",
            "bse_code": 500680,
            "isin": "INE182A01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Audit Report For The Financial Year Ended March 31, 2021",
            "news_body": "We submit herewith audited financial results for the financial year ended March 31, 2021, Statement of Assets and Liabilities as on March 31, 2021, Statement of Audited Cash Flows for the year ended March 31, 2021, Declaration with respect to Audit Report with unmodified opinion and the Auditor's Report by Auditors, M/s. Walker Chandiok & Co LLP, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.15 p.m. and concluded at 4.00 p.m.<BR> <BR> Further, please be informed that the Board of Directors of the Company has recommended a normal dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%), aggregating to total dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the year ended March 31, 2021.<BR> The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 15, 2021.<BR>",
            "news_id": "b752f9a2-a2df-4600-bcde-2d1d197db61d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a82dc2c-9586-4fb6-aa8a-fb114df5ae56.pdf",
            "news_date": "2021-05-26 16:27:26",
            "seo": "pfizer-ltd",
            "ltp": 5197.8,
            "ch": 237,
            "pch": 4.777455249153363,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 2643,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}